Indication
Post-kala-azar Dermal Leishmaniasis
1 clinical trial
2 products
Clinical trial
Assessing Safety and Efficacy of Repurposed Oral Ivermectin in PKDL TreatmentStatus: Recruiting, Estimated PCD: 2024-01-31
Product
IvermectinProduct
Miltefosine